Page 4 - Triple Negative News Today

Funds raised will benefit The Suzie Mackie Fellowship

According to Houston Methodist researchers who released results on a new combined therapy with the potential to improve outcomes for these hard-to-treat breast cancer patients, a drug used to treat cardiac failure has shown promising results in treating triple-negative breast cancer.

A drug used to treat cardiac failure has shown promising results in treating triple-negative breast cancer, according to Houston Methodist researchers who released results this week on a new combined therapy with the potential to improve outcomes for these hard-to-treat breast cancer patients.

12.12.2021 - Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today presented positive data from its ongoing global Phase 2 clinical ... Seite 1

- Expanded Phase 2 data set continues to provide compelling rationale for move to registrational clinical program - - Bomedemstat demonstrated durable clinical improvement in patients with ET who... | December 12, 2021

Crispy Innovation To Drive The Triple-Negative Breast Cancer Treatment Market

Crispy Innovation To Drive The Triple-Negative Breast Cancer Treatment Market

A vaccine against the most aggressive and deadly form of breast cancer is one step closer to reality.

Bonnie Cassen was first diagnosed with stage 3, hormone related breast cancer at the end of 2011. Ten years have come and gone, and unfortunately Bonnie is facing cancer yet again, only this time it’s classified as Stage IV Metastatic Triple Negative Breast Cancer.

The Pink Board Project seeks to raise awareness and funds for those fighting breast cancer through an online auction of boards from iconic shapers.